Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obese With Comorbidities”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableStudy completedNCT05072067
What this trial is testing

EFFICACY OF THE SLEEVE GASTROPLASTY WITH THE ENDOSCOPIC SYSTEM OVERSTICH SX ON WEIGHT LOSS AND REDUCTION OF CO-MORBIDITY FOR OBESE PATIENTS

Who this might be right for
Obesity
Clinique du Trocadéro 120
Not applicableStudy completedNCT06254339
What this trial is testing

Effects of OAGB and DJB-SG on 10-year and Lifetime Risks of MACE

Who this might be right for
Obesity
National Defense Medical Center, Taiwan 830
Not applicableUnknownNCT04034472
What this trial is testing

Interdisciplinary Weight Loss Therapy Associate With the Use of Interactive Digital Technology

Who this might be right for
Obesity
Federal University of São Paulo 80
Large-scale testing (Phase 3)Study completedNCT04184622
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Who this might be right for
OverweightObesity
Eli Lilly and Company 2,539
Not applicableStudy completedNCT06535295
What this trial is testing

Physical Activity, Functional Capacity and Quality of Life in Older Patients With Chronic Comorbidities

Who this might be right for
ObesityHypertensionType 2 Diabetes
Biruni University 148
Large-scale testing (Phase 3)Looking for participantsNCT07279194
What this trial is testing

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Who this might be right for
Obesity & Overweight
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 825
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Large-scale testing (Phase 3)Study completedNCT05822830
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

Who this might be right for
ObesityOverweight
Eli Lilly and Company 751
Post-approval studies (Phase 4)Looking for participantsNCT05872269
What this trial is testing

Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Who this might be right for
NAFLDObesityType 2 Diabetes+2 more
Zydus Lifesciences Limited 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06965413
What this trial is testing

Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightOverweight With One Weight Related Comorbidity
Hoffmann-La Roche 285
Large-scale testing (Phase 3)Active Not RecruitingNCT06047548
What this trial is testing

LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
OverweightObesity
Eli Lilly and Company 400
Not applicableStudy completedNCT01286389
What this trial is testing

Caloric Restriction in Obese Patients With Mild Cognitive Impairment: Effects on Adiposity, Comorbidity and Cognition

Who this might be right for
Mild Cognitive ImpairmentObesity
University of Sao Paulo General Hospital 80
Large-scale testing (Phase 3)Study completedNCT00325546
What this trial is testing

Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)

Who this might be right for
Obesity
Sanofi 643
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07292519
What this trial is testing

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

Who this might be right for
Alcohol Use Disorder (AUD)Overweight or ObeseComorbidities and Coexisting Conditions
South West Sydney Local Health District 46
Testing effectiveness (Phase 2)Study completedNCT05051579
What this trial is testing

LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

Who this might be right for
ObesityOverweight and Obesity
Eli Lilly and Company 272
Not applicableStudy completedNCT01137188
What this trial is testing

Effect of Weight Loss on Psoriasis

Who this might be right for
Psoriasis
University Hospital, Gentofte, Copenhagen 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06862791
What this trial is testing

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Who this might be right for
Obesity or Overweight
AstraZeneca 377
Not applicableLooking for participantsNCT06831994
What this trial is testing

Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity

Who this might be right for
Asthma BronchialeBreast NeoplasmsCoronary Disease+10 more
Universitätsklinikum Hamburg-Eppendorf 660
Large-scale testing (Phase 3)Study completedNCT06584916
What this trial is testing

Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

Who this might be right for
ObesityOverweight
Eli Lilly and Company 376
Large-scale testing (Phase 3)Study completedNCT04657016
What this trial is testing

Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

Who this might be right for
ObesityOverweight
Eli Lilly and Company 579
Load More Results